Thomas Lyons
Corporate Officer/Principal bei MARINUS PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Thomas Lyons
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas Lyons
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| POLYMEDIX, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Doctorate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Miami VA Health Care System / Research | Corporate Officer/Principal | ||
| The University of Miami Leonard M. Miller School of Medicine | College/University | Corporate Officer/Principal | |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Pharmaceuticals: Other | Director/Board Member | |
| DIAMEDICA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OPIANT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cnd Life Sciences, Inc.
 Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Medical/Nursing Services | Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| METAGENOMI, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PFENEX INC. | Biotechnology | Director/Board Member | |
| Juniata College | College/University | Undergraduate Degree | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member | |
JDP Therapeutics LLC
 JDP Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDP Therapeutics Inc. is a privately held, specialty pharmaceutical company focused on developing and commercializing proprietary product candidates for the treatment of life threatening diseases with significant unmet medical needs, principally for use in the hospital and urgent care settings. The company was founded by Jie Du in 2009 and is headquartered in Lansdale, PA. | Pharmaceuticals: Major | Director/Board Member | |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Deutschland | 3 |
| Schweiz | 2 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 38 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Health Services | 2 |
Operativ
| Director/Board Member | 123 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 46 |
| Chief Tech/Sci/R&D Officer | 28 |
| Undergraduate Degree | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nicole Vitullo | 28 |
| Scott Braunstein | 26 |
| Christopher Michael Cashman | 21 |
| Michael Dougherty | 18 |
| Tim Mayleben | 18 |
| Sarah Noonberg | 17 |
| Elan Ezickson | 17 |
| Seth Fischer | 17 |
| Santiago Arroyo | 14 |
| Martha Manning | 13 |
| Lorianne K. Masuoka | 12 |
| Sara Nochur | 11 |
| Edward Smith | 11 |
| Christine Silverstein | 10 |
| Enrique Carrazana | 9 |
- Börse
- Insiders
- Thomas Lyons
- Unternehmensverbindungen